Probiotics for the prevention of respiratory tract infections: a systematic review.

[1]  K. Zimmermann,et al.  [Reduction of acute recurrence in patients with chronic recurrent hypertrophic sinusitis by treatment with a bacterial immunostimulant (Enterococcus faecalis Bacteriae of human origin]. , 2011, Arzneimittel-Forschung.

[2]  D. Low,et al.  Reducing antibiotic use in influenza: challenges and rewards. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  G. Reid,et al.  Yogurt Containing Probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 Helps Resolve Moderate Diarrhea and Increases CD4 Count in HIV/AIDS Patients , 2008, Journal of clinical gastroenterology.

[4]  M. Boermeester,et al.  Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[5]  D. Pyne,et al.  Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes , 2008, British Journal of Sports Medicine.

[6]  A. Di Leo,et al.  Antagonistic Activity of Potential Probiotic Lactobacilli Against the Ureolytic Pathogen Yersinia enterocolitica , 2008, Current Microbiology.

[7]  L. Panasiuk,et al.  Empirical first-line antibioticotherapy in adult rural patients with acute respiratory tract infections. , 2007, Annals of agricultural and environmental medicine : AAEM.

[8]  D. Jonkers,et al.  Review article: probiotics in gastrointestinal and liver diseases , 2007, Alimentary pharmacology & therapeutics.

[9]  B. Kligler,et al.  Probiotics in children. , 2007, Pediatric clinics of North America.

[10]  I. Novotný,et al.  The effect of probiotics on gut flora, level of endotoxin and Child–Pugh score in cirrhotic patients: results of a double-blind randomized study , 2007, European journal of gastroenterology & hepatology.

[11]  M. Cabana,et al.  Probiotic and prebiotic influence beyond the intestinal tract. , 2007, Nutrition reviews.

[12]  L. Mousson,et al.  Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria. , 2007, Microbes and infection.

[13]  U. Wahn,et al.  Randomized, placebo‐controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy , 2007, Allergy.

[14]  S. Salminen,et al.  Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus , 2007, Letters in applied microbiology.

[15]  S. Park,et al.  The effect of probiotics on Helicobacter pylori eradication. , 2007, Hepato-gastroenterology.

[16]  G. Perdigón,et al.  The application of probiotics in cancer , 2007, British Journal of Nutrition.

[17]  L. Hammarström,et al.  Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies , 2007, BMC Microbiology.

[18]  M. Chennaoui,et al.  Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training. , 2007, Military medicine.

[19]  A. Suvorov,et al.  [Influence of probiotic enterococci on the growth of Streptococcus agalactiae]. , 2007, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.

[20]  T. Haahtela,et al.  The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners. , 2007, International journal of sport nutrition and exercise metabolism.

[21]  J. Xaus,et al.  [Beneficial effects of consumption of a dairy product containing two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714 in healthy children]. , 2007, Nutricion hospitalaria.

[22]  M. Falagas,et al.  Probiotics for the treatment of women with bacterial vaginosis. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  M. Leinonen,et al.  Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study. , 2007, Clinical nutrition.

[24]  Y. Sanz,et al.  Probiotics as drugs against human gastrointestinal infections. , 2007, Recent patents on anti-infective drug discovery.

[25]  J. D. Young,et al.  The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review. , 2007, Clinical nutrition.

[26]  H. Paik,et al.  Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine , 2007, Letters in applied microbiology.

[27]  G. Famularo,et al.  Use of probiotics for prevention of radiation-induced diarrhea. , 2007, World journal of gastroenterology.

[28]  M. Geier,et al.  Probiotics, prebiotics and synbiotics: A role in chemoprevention for colorectal cancer? , 2006, Cancer biology & therapy.

[29]  M. Falagas,et al.  Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. , 2006, The Journal of antimicrobial chemotherapy.

[30]  J. Villena,et al.  Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. , 2006, Microbes and infection.

[31]  J. Sanz,et al.  Efecto de Lactobacillus casei sobre la incidencia de procesos infecciosos en niños/as , 2006 .

[32]  C. Hammerman,et al.  Probiotics and neonatal intestinal infection , 2006, Current opinion in infectious diseases.

[33]  P. Heczko,et al.  Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains – a randomized, double‐blind, placebo‐controlled trial , 2006, Alimentary pharmacology & therapeutics.

[34]  A. Zachrisson,et al.  Increasing work-place healthiness with the probiotic Lactobacillus reuteri: A randomised, double-blind placebo-controlled study , 2005, Environmental health : a global access science source.

[35]  G. Perdigón,et al.  Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. , 2005, Immunobiology.

[36]  J. Hampe,et al.  Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. , 2005, Clinical nutrition.

[37]  M. de Vrese,et al.  Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. , 2005, International journal of clinical pharmacology and therapeutics.

[38]  Itzhak Brook,et al.  The Role of Bacterial Interference in Otitis, Sinusitis and Tonsillitis , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[39]  J. Villena,et al.  Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. , 2005, The Journal of nutrition.

[40]  Z. Weizman,et al.  Effect of a Probiotic Infant Formula on Infections in Child Care Centers: Comparison of Two Probiotic Agents , 2005, Pediatrics.

[41]  C. Mcnaught,et al.  Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. , 2004, Clinical nutrition.

[42]  E. Benchimol,et al.  Probiotics in Relapsing and Chronic Diarrhea , 2004, Journal of pediatric hematology/oncology.

[43]  H. Yasui,et al.  Reduction of Influenza Virus Titer and Protection against Influenza Virus Infection in Infant Mice Fed Lactobacillus casei Shirota , 2004, Clinical Diagnostic Laboratory Immunology.

[44]  J. Schrezenmeir,et al.  Benefits of Oral Supplementation With and Without Synbiotics in Young Children With Acute Bacterial Infections , 2004, Clinical pediatrics.

[45]  D. Sgouras,et al.  In Vitro and In Vivo Inhibition of Helicobacter pylori by Lactobacillus casei Strain Shirota , 2004, Applied and Environmental Microbiology.

[46]  Gregor Reid,et al.  Potential Uses of Probiotics in Clinical Practice , 2003, Clinical Microbiology Reviews.

[47]  B. Cukrowska,et al.  Oral Administration of Probiotic Escherichia coli after Birth Reduces Frequency of Allergies and Repeated Infections Later in Life (after 10 and 20 Years) , 2003, International Archives of Allergy and Immunology.

[48]  J. Tagg,et al.  Bacterial replacement therapy: adapting 'germ warfare' to infection prevention. , 2003, Trends in biotechnology.

[49]  M. L. Cross.  Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. , 2002, FEMS immunology and medical microbiology.

[50]  J. Schnürer,et al.  Lactobacillus plantarum MiLAB 393 Produces the Antifungal Cyclic Dipeptides Cyclo(l-Phe-l-Pro) and Cyclo(l-Phe-trans-4-OH-l-Pro) and 3-Phenyllactic Acid , 2002, Applied and Environmental Microbiology.

[51]  A. Oláh,et al.  Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis , 2002, The British journal of surgery.

[52]  Liliana Zago,et al.  El estado nutricional modifica la efectividad de un suplemento dietario de bacterias lácticas sobre la aparición de patologías de vías respiratorias en niños , 2002 .

[53]  M. Nader-Macías,et al.  Protective effect of intranasally inoculated Lactobacillus fermentum against Streptococcus pneumoniae challenge on the mouse respiratory tract. , 2001, FEMS immunology and medical microbiology.

[54]  R Korpela,et al.  Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial , 2001, BMJ : British Medical Journal.

[55]  R. Gonzales,et al.  Principles of Appropriate Antibiotic Use for Treatment of Nonspecific Upper Respiratory Tract Infections in Adults: Background , 2001, Annals of Internal Medicine.

[56]  H. Müller-Alouf,et al.  Mucosal Immune Responses and Protection against Tetanus Toxin after Intranasal Immunization with RecombinantLactobacillus plantarum , 2001, Infection and Immunity.

[57]  T. Matsuzaki,et al.  Immunomodulatory function of lactic acid bacteria. , 1999 .

[58]  H. Yasui,et al.  Protection against Influenza Virus Infection of Mice Fed Bifidobacterium breve YIT4064 , 1999, Clinical Diagnostic Laboratory Immunology.

[59]  M. Kurimoto,et al.  Lactobacilli and Streptococci Induce Interleukin-12 (IL-12), IL-18, and Gamma Interferon Production in Human Peripheral Blood Mononuclear Cells , 1998, Infection and Immunity.

[60]  A R Jadad,et al.  Assessing the Quality of Randomized Controlled Trials: Current Issues and Future Directions , 1996, International Journal of Technology Assessment in Health Care.

[61]  G. Reid,et al.  Influence of lactobacilli on the adhesion ofStaphylococcus aureus andCandida albicans to fibers and epithelial cells , 1995, Journal of Industrial Microbiology.

[62]  M. Saxelin,et al.  Lactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis , 1995, Journal of pediatric gastroenterology and nutrition.

[63]  A R Jadad,et al.  Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. , 1995, Controlled clinical trials.

[64]  C. Pothoulakis,et al.  Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. , 1993, Gastroenterology.

[65]  E. Soppi,et al.  Enhancement of the Circulating Antibody Secreting Cell Response in Human Diarrhea by a Human Lactobacillus Strain , 1992, Pediatric Research.

[66]  G. Perdigón,et al.  Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections , 1991, Journal of Dairy Research.

[67]  K. Wilson,et al.  Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora , 1988, Infection and immunity.

[68]  S. Gorbach,et al.  Antimicrobial substance from a human Lactobacillus strain , 1987, Antimicrobial Agents and Chemotherapy.

[69]  G. Perdigón,et al.  Effect of perorally administered lactobacilli on macrophage activation in mice , 1986, Infection and immunity.

[70]  M. Ohwaki,et al.  Induction by Lactobacillus casei of increase in macrophage colony-forming cells and serum colony-stimulating activity in mice. , 1986, Japanese journal of cancer research : Gann.

[71]  M. Falagas,et al.  Probiotics for the Treatment or Prevention of Atopic Dermatitis , 2008, American journal of clinical dermatology.

[72]  P. Steenhout,et al.  Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics. , 2007, Nutrition.

[73]  S. Salminen,et al.  Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus. , 2006, Asia Pacific journal of clinical nutrition.

[74]  P. Gayral,et al.  Inhibitory activity of saccharomyces yeasts on the adhesion ofEntamoeba histolytica trophozoites to human erythrocytes in vitro , 2004, Parasitology Research.

[75]  J. Antoine,et al.  Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. , 2003, The journal of nutrition, health & aging.

[76]  M. Pochapin.  The effect of probiotics on Clostridium difficile diarrhea. , 2000, The American journal of gastroenterology.

[77]  R. Clemens,et al.  Probiotic spectra of lactic acid bacteria (LAB). , 1999, Critical reviews in food science and nutrition.

[78]  H. Akaza,et al.  Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. , 1995, European urology.